GLPwatch
Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome
NCT05965908 · Completed
Last updated 2026-05-28This clinical trial tested whether the medication liraglutide helps reduce body weight in obese women who have polycystic ovary syndrome.
Status Completed The study has finished.
Phase Phase 3 Confirms effectiveness in a large group before approval.
Type Interventional (clinical trial)
Design Randomized, open-label (no blinding) treatment study
Participants 150 people
Who can join Ages 20–40 · female only
Timeline Started 2024-01 · est. completion 2025-03
Where 1 site · Egypt
What this study is testing ClinicalTrials.gov NCT05965908 ↗
Description as written by the study sponsor.
The aim of this study is to compare the hormonal, metabolic and clinical effects of metformin and liraglutide in infertile women with PCOs.
Treatments tested
- liraglutide also known as saxenda ampoules Drug
glucagon-like peptide 1 receptor agonist
- Metformin also known as Glucophage 1000mg Drug
biguanide antihyperglycemic
| Main thing measured | Body weight loss |
|---|---|
| Sponsor | Beni-Suef University |
| Conditions studied | Polycystic Ovary |
| GLP-1 drugs | liraglutide |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT05965908 ↗